BIOMAT Database Logo BIOMAT Database Logo

Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review. 1983

R K Mishra, and S Chiu, and P Chiu, and C P Mishra

UI MeSH Term Description Entries
D009075 MSH Release-Inhibiting Hormone A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES. MSH Release-Inhibiting Factor,Melanocyte-Stimulating Hormone Release-Inhibiting Hormone,Prolyl-Leucyl-Glycinamide,H-Pro-Leu-Gly-NH2,MIF-1,MIF-I,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,Melanostatin,Oxytocin (7-9),Pro-Leu-Gly-NH2,Pro-Leu-Glyamide,Prol-Leu-Gly-NH2,Prolylleucylglycinamide,Prol Leu Gly NH2,Prolyl Leucyl Glycinamide
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.
November 1976, Life sciences,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
[Mechanism of PLG (L-prolyl-L-leucyl-glycinamide) in treating Parkinson's disease].
August 1985, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
L-prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of cats.
December 1973, Brain research,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
November 1986, Life sciences,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
January 1982, Peptides,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Effects of the neuropeptide PLG (L-prolyl-leucyl-glycinamide) on writing pressure and speed in healthy subjects.
November 1988, Pharmacopsychiatry,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
August 1999, Bioorganic & medicinal chemistry letters,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Beta-analogs of PLG (L-prolyl-L-leucyl-glycinamide): ex-chiral pool syntheses and dopamine D2 receptor modulating effects.
October 1998, Bioorganic & medicinal chemistry letters,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
The action of prolyl-leucyl-glycinamide (PLG) on the nigrostriatal pathway of the rat.
June 1990, Arquivos de neuro-psiquiatria,
R K Mishra, and S Chiu, and P Chiu, and C P Mishra
Memory enhancement induced in chicks by L-prolyl-L-leucyl-glycinamide.
November 1982, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!